Table 4.
Site of progression | n event/n total | median OS¥ (mo) | SD(±) | 95% CI* | p |
---|---|---|---|---|---|
Brain | |||||
(−) | 32/69 | 61.0 | 9.7 | (41.8–80.0) | 0.041 |
(+) | 5/7 | 32.0 | 10.4 | (11.6–52.3) | |
Liver | |||||
(−) | 29/63 | 61.0 | 9.5 | (42.3–74.6) | 0.400 |
(+) | 8/13 | 47.0 | 15.2 | (17.0–76.9) | |
Lung | |||||
(−) | 24/52 | 59.0 | 8.4 | (42.5–75.4) | 0.332 |
(+) | 13/24 | 48.0 | 10.9 | (26.4–69.5) | |
Bone | |||||
(−) | 29/58 | 52.0 | 10.1 | (32.0–71.9) | 0.647 |
(+) | 8/18 | 59.0 | 11.4 | (36.5–81.4) |
OS: Overall survival
CI: Confidence Interval